Back to search

Article

Discovery of potent oligopeptides for various metabolic diseases using deep learning

2026-01-07

Abstract excerpt

<h4>SUMMARY</h4> Artificial intelligence (AI)-based methods are increasingly critical in peptide drug discovery, but their applications are limited in a narrow scope such as antimicrobial peptides. For indications where peptide therapy inherently excels, such as metabolism, endocrinology, and tissue regeneration, AI-based pipeline for therapeutic peptide discovery is long awaited but still unmet. Here, we propose...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a5f46949-d792-5c50-aea0-efdb9e01a5ca
DOI
10.64898/2026.01.06.697667
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discovery of potent oligopeptides for various metabolic diseases using deep learningDOI 10.64898/2026.01.06.697667
Select a neighboring publication to make it the new centre.